
Sign up to save your podcasts
Or
Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
4.4
6262 ratings
Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
17 Listeners
32 Listeners
14 Listeners
672 Listeners
13 Listeners
70 Listeners
0 Listeners
111 Listeners
45 Listeners
496 Listeners
57 Listeners
101 Listeners
45 Listeners
61 Listeners
8,600 Listeners
170 Listeners